TY - JOUR
T1 - Efficient construction of a diabody using a refolding system
T2 - Anti-carcinoembryonic antigen recombinant antibody fragment
AU - Asano, Ryutaro
AU - Kudo, Toshio
AU - Nishimura, Yukihiro
AU - Makabe, Koki
AU - Hayashi, Hiroki
AU - Suzuki, Masanori
AU - Tsumoto, Kouhei
AU - Kumagai, Izumi
PY - 2002/12/1
Y1 - 2002/12/1
N2 - Recombinant fragments of the variable region of antibodies are useful in many experimental and clinical applications. However, it can be difficult to obtain these materials in soluble form after their expression in bacteria. Here, we report an efficient procedure for preparing several variable-domain fragments (Fv), single-chain Fv (scFv), and a diabody (the smallest functional bispecific antibody) of anti-carcinoembryonic antigen (CEA) antibody by overexpression in Escherichia coli in inclusion bodies, using a refolding system to obtain renatured proteins. Two types of refolded Fv were prepared: (i) Heavy and light chains of the immunoglobulin variable regions (VH and VL, respectively) were coexpressed with a dicistronic expression vector (designated Fvco); (ii) VH and VL were expressed separately, mixed stoichiometrically, and refolded (designated Fvmix). All samples refolded with high efficiency; Fvco, Fvmix, scfv, and the bispecific diabody bound to several CEA-positive cell lines, exactly as did soluble Fv fragments secreted by E. coli (Fvsol) and the parent IgG. The refolded fragments inhibited binding of the parent IgG to CEA-positive cell lines, indicating that their epitope is identical to that of IgG. The bispecific diabody, which combined variable-region fragments of anti-CEA antibody with variable-region fragments of anti-CD3 antibody, was also prepared using the refolding system. This refolded diabody could bind to lymphokine-activated killer cells. In addition, its cytotoxicity toward human bile duct carcinoma TFK-1 and other several other CEA-positive cell lines was concentration-dependent. Taken together, our results suggest that a refolding procedure can be used to prepare various functional antibody fragments (Fv, scfv, and diabody).
AB - Recombinant fragments of the variable region of antibodies are useful in many experimental and clinical applications. However, it can be difficult to obtain these materials in soluble form after their expression in bacteria. Here, we report an efficient procedure for preparing several variable-domain fragments (Fv), single-chain Fv (scFv), and a diabody (the smallest functional bispecific antibody) of anti-carcinoembryonic antigen (CEA) antibody by overexpression in Escherichia coli in inclusion bodies, using a refolding system to obtain renatured proteins. Two types of refolded Fv were prepared: (i) Heavy and light chains of the immunoglobulin variable regions (VH and VL, respectively) were coexpressed with a dicistronic expression vector (designated Fvco); (ii) VH and VL were expressed separately, mixed stoichiometrically, and refolded (designated Fvmix). All samples refolded with high efficiency; Fvco, Fvmix, scfv, and the bispecific diabody bound to several CEA-positive cell lines, exactly as did soluble Fv fragments secreted by E. coli (Fvsol) and the parent IgG. The refolded fragments inhibited binding of the parent IgG to CEA-positive cell lines, indicating that their epitope is identical to that of IgG. The bispecific diabody, which combined variable-region fragments of anti-CEA antibody with variable-region fragments of anti-CD3 antibody, was also prepared using the refolding system. This refolded diabody could bind to lymphokine-activated killer cells. In addition, its cytotoxicity toward human bile duct carcinoma TFK-1 and other several other CEA-positive cell lines was concentration-dependent. Taken together, our results suggest that a refolding procedure can be used to prepare various functional antibody fragments (Fv, scfv, and diabody).
KW - Adoptive immunotherapy
KW - Bispecific diabody
KW - CEA
KW - Inclusion body
UR - http://www.scopus.com/inward/record.url?scp=0036947103&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036947103&partnerID=8YFLogxK
U2 - 10.1093/oxfordjournals.jbchem.a003303
DO - 10.1093/oxfordjournals.jbchem.a003303
M3 - Article
C2 - 12473192
AN - SCOPUS:0036947103
SN - 0021-924X
VL - 132
SP - 903
EP - 909
JO - Journal of Biochemistry
JF - Journal of Biochemistry
IS - 6
ER -